January Is a Month, Not a Condition: Auditing CBD Mood Marketing in the UK
Photo: Andy Stephenson , CC BY-SA 2.0, via Wikimedia Commons
The calendar as a sales instrument
Blue Monday was not discovered; it was commissioned. The phrase was devised in 2005 on behalf of a travel company, dressed up with an equation and handed to the press, and it has been recycled every January since. By 2026 the third Monday of the month functions less as a date than as a slot in the retail calendar.
For the CBD sector it is a particularly convenient slot. January arrives with a genuine public mood to address: dark mornings, post-Christmas fatigue, the flatness that follows a fortnight of unusual eating, drinking and spending. What the shelf offers in response is a vocabulary — reset, balance, calm, seasonal support — that sounds clinical without committing to anything a regulator could measure.
This is not a failing unique to CBD. But cannabidiol sits in an awkward place, sold as a food supplement while marketed in the register of medicine, and January is when that tension becomes most visible.
Where the line actually sits
Under UK food law, a CBD product sold as a food supplement may not attribute to itself the property of preventing, treating or curing a human disease. That is a bright line. A product page may not state that the oil eases anxiety, lifts low mood or settles seasonal depression, because each of those is a medicinal claim requiring an authorisation the product does not hold.
Behind that line there is a broad grey band. Permitted health claims in Great Britain are drawn from a fixed register, and each is tied to a named nutrient — vitamin D and normal immune function, for instance. There is no authorised claim for cannabidiol. A brand that wishes to sound helpful must therefore do it by association: photographs of a bath, a sunrise, a person in a dressing gown holding a mug; words such as ‘support’, ‘balance’ and ‘reset’ left deliberately unanchored; and testimonials that make the assertion the brand cannot.
The Advertising Standards Authority has been consistent on this territory. Its code requires evidence to be held before publication, proportionate to the strength of the claim, and it has upheld complaints across the sector concerning anxiety, sleep and pain. Reposting a customer’s confident assertion is not an exemption.
Two further pieces of scaffolding are worth knowing. The Food Standards Agency publishes a list of CBD products it considers to be progressing through novel food authorisation, and it advises healthy adults to consume no more than 10mg of CBD per day. Guidance is not statute, but it is the correct yardstick for judging whether a page has been written by adults.
Three questions for any page in January
First, does the sentence make a claim about the product or about the routine? ‘A quiet ten minutes before bed’ is a routine. ‘Supports restful sleep’ printed beneath a bottle is a claim wearing a routine’s coat.
Second, is the evidence about this product? A reference list populated with general cannabinoid research, none of it involving the formulation in the basket, is decoration rather than substantiation.
Third, does the page say what the product cannot do? Careful operators tend to include a paragraph noting that it is not a medicine, not suitable in pregnancy or breastfeeding, and not for anyone under 18. That paragraph costs sales, which is precisely why its presence tells you something.
The testimonial problem
January reviews share a narrative shape: a low month, a purchase, a change a fortnight later. What such accounts cannot show is what would have happened without the purchase — the light returning, the social calendar restarting, sleep normalising after the Christmas disruption, or simply the relief of having bought something. None of that is dishonesty; it is the ordinary structure of memory. It does mean a wall of praise records experiences rather than establishing evidence.
A routine that outlasts the calendar
If a CBD habit is to be worth keeping, it should be judged after January has finished. A workable method looks like this.
Set the review date before you buy, not after a countdown timer has done its work. Decide in advance what would count as a reason to continue and what would count as a reason to stop.
Change one thing at a time. If you begin taking oil in the same week that you begin morning walks and a 10pm phone curfew, you will never establish which element is doing what.
Keep a short log: date started, product name, batch or lot number, amount taken, time of day, and a single line on how the week felt. Four weeks is a reasonable first look, and a written record is harder to rewrite in hindsight than a memory is.
Ask what the brand would say in July. If the page reads differently out of season, the copy was never about you.
Finally, treat seasonal low mood on its own terms. If the pattern is severe, persistent, and affecting work or relationships, that is a conversation with a GP rather than a checkout. Daylight, sleep timing, movement and company are unglamorous and free, and they appear in every January feature for a reason.
The third Monday is a construct. Your routine does not have to be.